0% found this document useful (0 votes)
78 views1 page

CS Algorithm

This document provides guidelines for evaluating and treating infants exposed to syphilis in utero. It outlines 4 scenarios based on the infant and mother's criteria. Scenario 1 indicates proven or highly probable congenital syphilis and requires a CSF analysis and full treatment of the infant. Scenario 2 indicates possible congenital syphilis and requires a more limited infant evaluation. Scenario 3 is less likely congenital syphilis and may not require infant treatment if follow-up can be certain. Scenario 4 is not discussed but involves an adequately treated mother.

Uploaded by

Draalex
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
78 views1 page

CS Algorithm

This document provides guidelines for evaluating and treating infants exposed to syphilis in utero. It outlines 4 scenarios based on the infant and mother's criteria. Scenario 1 indicates proven or highly probable congenital syphilis and requires a CSF analysis and full treatment of the infant. Scenario 2 indicates possible congenital syphilis and requires a more limited infant evaluation. Scenario 3 is less likely congenital syphilis and may not require infant treatment if follow-up can be certain. Scenario 4 is not discussed but involves an adequately treated mother.

Uploaded by

Draalex
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

CONGENITAL SYPHILIS (CS)

Evaluation and treatment of infants (<30 days old) exposed to syphilis in utero*
Start INFANTS AND BIRTHING PARENT (e.g., mother) SHOULD HAVE SERUM RPR OR VDRL TITER DRAWN AT DELIVERY

Infant Criteria: Maternal Criteria: Additional Maternal Criteria:

• CS findings on physical exam • Not treated • Adequately treated with benzathine penicillin
No to all No to all
• Infant titer ≥4 fold higher than mother’s titer • Inadequately treated§ G appropriate for stage, initiated ≥30 days
• + darkfield or PCR of placenta, cord lesion, • Treatment undocumented before delivery
or body fluid • Treated with a non-benzathine penicillin G regimen AND
• + silver stain of placenta or cord • Initiated treatment <30 days before delivery • No concern for reinfection or treatment failure

Scenario 1: Scenario 2: Scenario 3:


Yes to any Yes to any Yes to both
Proven or Highly Possible CS
II
Less Likely CS
Probable CS
Infant Evaluation: No additional infant evaluation
Infant Evaluation:

† • CSF analysis
• CSF analysis
VDRL, cell count, and protein
VDRL, cell count, and protein Review Maternal Titers & Stage:
• CBC, differential, and platelet count
• Complete blood count (CBC), differential
• Long-bone radiographs
and platelet count • ≥4-fold decrease in titer after treatment for early syphilis
• Long-bone radiographs OR
• Tests as clinically indicated by signs on Any abnormalities, • Stable titer for low-titer, latent syphilis (RPR < 1:4 or
physical exam. results not available, VDRL<1:2)
No abnormalities
OR follow-up¶ uncertain AND
follow-up¶ certain
No to both Yes to either
OR AND
Infant Treatment: follow-up¶ uncertain follow-up¶ certain

Aqueous crystalline penicillin G Infant Treatment:
No treatment indicated
100,000–150,000 units/kg/day, administered as 50,000 Benzathine penicillin G
units/kg/dose IV every 12 hours during the first 7 days of life with close serologic follow-up of infant every 2-3
and every 8 hours thereafter for a total of 10 days 50,000 units/kg/dose IM in a single dose months for 6 months

* Scenario 4 – in which an infant at delivery has a normal physical exam and titer < 4-fold mother’s titer, AND the mother was adequately treated prior to becoming pregnant and sustains RPR titers <1:4 or
VDRL<1:2 throughout pregnancy – is not included.
† CSF test results obtained during the neonatal period can be difficult to interpret; normal values differ by gestational age and are higher in preterm infants.
‡ Alternative: Procaine penicillin G 50,000 units/kg/dose IM in a single daily dose for 10 days.
§ Benzathine Penicillin G (BPG or Bicillin-LA), administered according to stage of disease and initiated at least 30 days prior to delivery is the only adequate treatment for syphilis during pregnancy.
II Evaluation is not necessary if a 10-day course of parenteral therapy is administered, although such evaluations might be useful. If the neonate’s nontreponemal test is nonreactive and the mother’s risk for
untreated syphilis is low, a single IM dose of BPG can be considered without evaluation.
¶ All neonates with reactive nontreponemal tests should receive careful follow-up examinations and serologic testing (i.e., a nontreponemal test) every 2–3 months until the test becomes nonreactive. Neonates with
a negative nontreponemal test at birth whose mothers were seroreactive at delivery should be retested at 3 months to rule out serologically negative incubating congenital syphilis at the time of birth.
FOR MORE INFORMATION ABOUT SCENARIO 4 MANAGEMENT, TREATMENT OF SYPHILIS IN PREGNANCY, NEONATAL CSF INTERPRETATION, AND CS INFANT FOLLOW-UP, PLEASE REFER TO
THE CDC 2021 STI TREATMENT GUIDELINES. Revised 2/2022

You might also like